Method for the treatment of moderate chronic periodontitis with dysbacteriosis

A clinical and epidemiological study was conducted in groups with dysbiosis (n=504) and without dysbiosis (n=732) aged from 15 to 74 years. At the same time, the developed method for the treatment of chronic generalized periodontitis was used in 328 patients aged 35 to 48 years with concomitant gastrointestinal diseases and laboratory-established grade 2 dysbiosis of the large intestine. In the course of complex treatment to restore oral dysbiosis, a therapeutic paste was used locally with administration into the periodontal pocket based on synbiotic “Bifikin Forte” 20 billion CFU, oil solution of vitamin “A” and zinc oxide with subsequent fixation with protective dressing “Parasept”. In addition, oral administration of synbiotic “Bifikin Forte” 20 billion CFU was prescribed. Results. Application of synbiotic in complex treatment of chronic periodontitis promotes stimulation of growth of beneficial bacteria and reduction of pathogenic microflora in periodontal pocket with subsequent reduction of intensity of inflammatory process, edema and bleeding of periodontal tissues. The developed method causes the increase of clinical effectiveness of treatment of periodontal diseases characterized by inflammatory-destructive process of periodontal tissues, prevention of chronic foci of infection in the maxillofacial area.

1. Avduev I.S. Therapeutic aspects of diseases of the gastrointestinal tract and analysis of the range of medicines used for the treatment and prevention of diseases of the digestive system // Bulletin of Biomedicine and Sociology. 2022.73. Р.80-84. DOI: 10.26787/ nydha-2618-8783-2022-7-3-80-84.

2. Analysis of the etiopathogenesis of dysbiosis in dentistry (literature review) / Vecherkina Zh.V., Chirkova N.V., Shalimova N.A. [et al.] // Bulletin of new medical technologies. 2020. Vol. 27. No.3. P.11-19.

3. Bulgakovа A.I., Soldatova E.S., Kuvardina Yu.O. / Optimization of chronic periodontitis comprehensive treatment // Parodontologiya. 2023.28. No.4. Р.431-436. https://doi.org/10.33925/1683-3759-2023-840.

4. Zykova A.S., Opravin A.S., Soloviev A.G. / Periodontitis as a risk factor for cardiovascular disease development: systematic review // Parodontologiya. 2024. No.29. P.25-33. https://doi.org/10.33925/1683-3759-2024-806.

5. Iordanishvili A.K., Guk V.A., Golovko A.A. / Complex treatment of periodontitis: patient’s reaction to the therapy // Parodontologiya. 2020. Vol.25. No.2. Р.97-100. https://doi.org/10.33925/1683-3759-2020-25-2-97-100.

6. Microbiological landscape of the periodontal pocket in inflammatory diseases in periodontal tissues / Miklyaev S.V., Leonova O.M., Sushchenko A.V. [et al.] // Bulletin of RUDN University. Series: Medicine. 2021. No. 4. Р. 332-338.

7. The efficacy of bacteriophage/probiotic combination therapy in periodontal treatment / Galieva A.S., Davidovich N.V., Opravin A.S. [et al.] // Parodontologiya. 2024.29. No.1. Р.92-101. https://doi.org/10.33925/1683-3759-2024-821.

8. Cross-sectional study on the association of periodontitis with arterial hypertension in the Hamburg City Health Study / Könnecke H, Schnabel RB, Walther C, [et al.] European Journal of Medical Research. 2022.27(1). Р.181.

9. The Effect of Non-Surgical Periodontal Treatment on Patients with Combined Refractory Arterial Hypertension and Stage III, Grade B Periodontitis: A Preliminary Prospective Clinical study / Rodrigues JVS, Cláudio M.M, Franciscon JPS [et al.] Journal of Clinical Medicine. 2023.12(13).Р.4277.